X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10) 10
humans (9) 9
female (8) 8
oncology (7) 7
aged (6) 6
chemotherapy (6) 6
male (6) 6
adult (5) 5
dermatology (5) 5
metastasis (5) 5
middle aged (5) 5
cancer therapies (3) 3
cell biology (3) 3
clinical trials (3) 3
drug therapy (3) 3
gemcitabine (3) 3
medical research (3) 3
pancreatic cancer (3) 3
studies (3) 3
survival (3) 3
therapy (3) 3
young adult (3) 3
adenocarcinoma (2) 2
adolescent (2) 2
analysis (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bevacizumab (2) 2
cancer (2) 2
chemotherapy, adjuvant (2) 2
colorectal cancer (2) 2
deoxycytidine - analogs & derivatives (2) 2
folfirinox (2) 2
guidelines (2) 2
hematology, oncology and palliative medicine (2) 2
human genetics (2) 2
ilds newsletter (2) 2
leucovorin (2) 2
medical prognosis (2) 2
medicine, experimental (2) 2
metastases (2) 2
missing data (2) 2
multicenter (2) 2
neoplasm staging (2) 2
outcomes (2) 2
pain (2) 2
pancreatic neoplasms - drug therapy (2) 2
pancreatic neoplasms - pathology (2) 2
patients (2) 2
product development (2) 2
quality of life (2) 2
survival rate (2) 2
treatment outcome (2) 2
18th century (1) 1
1st-line treatment (1) 1
2nd-line (1) 1
3' untranslated regions (1) 1
acetyltransferases - metabolism (1) 1
acne (1) 1
acne vulgaris - chemically induced (1) 1
acne vulgaris - drug therapy (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - surgery (1) 1
adjuvant treatment (1) 1
adrenal cortex hormones - therapeutic use (1) 1
advanced basic science (1) 1
africa, northern (1) 1
aged, 80 and over (1) 1
anti-infective agents - adverse effects (1) 1
anti-infective agents - therapeutic use (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antibodies, monoclonal, humanized - adverse effects (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antirheumatic drugs (1) 1
assessing comedogenic substances (1) 1
atopic dermatitis (1) 1
autoimmune diseases - complications (1) 1
avelumab (1) 1
base sequence (1) 1
biochemistry & molecular biology (1) 1
biological response modifiers (1) 1
biomedicine (1) 1
birth outcomes (1) 1
blood-pressure (1) 1
bordeaux (1) 1
breast cancer (1) 1
breast-cancer (1) 1
calcineurin inhibitors (1) 1
camptothecin - administration & dosage (1) 1
camptothecin - analogs & derivatives (1) 1
cancer clinical-trials (1) 1
carbohydrate (1) 1
care and treatment (1) 1
case and review (1) 1
case report (1) 1
cetuximab (1) 1
chemokine cxcl9 - biosynthesis (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 862 - 873
Summary Background Since the 1990s, fluorouracil-based adjuvant chemotherapy has significantly reduced the risk of tumour recurrence in patients with stage III... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | THERAPY | ONCOLOGY | BEVACIZUMAB | ADJUVANT TREATMENT | NSABP C-07 | KRAS | COMBINATION | METASTATIC COLORECTAL-CANCER | CHEMOTHERAPY | ras Proteins - genetics | Colonic Neoplasms - genetics | Proto-Oncogene Proteins p21(ras) | Adenocarcinoma - pathology | Colonic Neoplasms - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Diarrhea - chemically induced | Colonic Neoplasms - surgery | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Infusions, Intravenous - adverse effects | Adult | Female | Leucovorin - therapeutic use | Adenocarcinoma - genetics | Chemotherapy, Adjuvant | Cetuximab | Antibodies, Monoclonal, Humanized - adverse effects | Drug Eruptions - etiology | Exons - genetics | Proto-Oncogene Proteins - genetics | Adenocarcinoma - drug therapy | Mucositis - chemically induced | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Colonic Neoplasms - pathology | Intention to Treat Analysis | Aged | Neoplasm Staging | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Adenocarcinoma - surgery | Prevention | Care and treatment | Chemotherapy | Colon cancer | Hospitals | Leucovorin | Product development | Cancer | Life Sciences
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 801 - 810
Journal Article
Journal Article
Pigment Cell & Melanoma Research, ISSN 1755-1471, 05/2014, Volume 27, Issue 3, pp. 398 - 407
Journal Article
Future Oncology, ISSN 1479-6694, 02/2019, Volume 15, Issue 6, pp. 567 - 577
Avelumab is a human anti-PD-L1 IgG1 monoclonal antibody that has shown antitumor activity in early phase studies in advanced/metastatic... 
gastric cancer | PD-L1 | avelumab | PATHWAYS | SUPPORTIVE CARE | 2ND-LINE | THERAPY | ONCOLOGY | BEVACIZUMAB | SOLID TUMOR
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2015, Volume 10, Issue 5, p. e0125350
Background A randomized multicenter phase II trial was conducted to assess the sequential treatment strategy using FOLFIRI.3 and gemcitabine alternately ( Arm... 
BREAST-CANCER | PATTERN-MIXTURE-MODELS | FOLFIRINOX | CANCER CLINICAL-TRIALS | ONCOLOGY | PROPENSITY SCORE METHODS | MULTIDISCIPLINARY SCIENCES | GUIDELINES | MISSING DATA | OUTCOMES | GEMCITABINE | Lung Neoplasms - drug therapy | Multivariate Analysis | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Liver Neoplasms - mortality | Pancreatic Neoplasms - drug therapy | Deoxycytidine - therapeutic use | Lung Neoplasms - secondary | Adult | Female | Surveys and Questionnaires | Pancreatic Neoplasms - mortality | Quality of Life - psychology | Liver Neoplasms - secondary | Pancreatic Neoplasms - pathology | Liver Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols | Liver Neoplasms - psychology | Antimetabolites, Antineoplastic - therapeutic use | Survival Analysis | Pancreatic Neoplasms - psychology | Aged | Health Status | Lung Neoplasms - psychology | Longitudinal Studies | Research Design | Deoxycytidine - analogs & derivatives | Gemcitabine | Pancreatic cancer | Patient outcomes | Research | Drug therapy | Health aspects | Quality of life | Adenocarcinoma | Clinical trials | Oncology | Metastasis | Cancer therapies | Metastases | Randomization | Pain | Gastroenterology | Pancreas | Public health | Statistical analysis | Health | Breast cancer | Regression analysis | Patients | Survival | Studies | Missing data | Chemotherapy | Deterioration | Medical prognosis | Methods
Journal Article
Dermatology, ISSN 1018-8665, 07/2012, Volume 224, Issue 3, pp. 285 - 288
Journal Article
Dermatology, ISSN 1018-8665, 05/2012, Volume 224, Issue 2, pp. 189 - 192
Journal Article
2010, ISBN 9783540693604
A particular form of vitiligo reported as ‘infl ammatory vitiligo with raised borders’ has been rarely described, and this condition is associated with... 
Human Genetics | Plastic Surgery | Internal Medicine | Medicine & Public Health | Dermatology | Cell Biology
Book Chapter
Journal Article